13 December 2024 - Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema treatment on the Pharmaceutical Benefits Scheme, saving patients about $20,000 a year.

After higher than anticipated uptake risked that drug sponsor Sanofi would withdraw the medicine from the PBS, the Federal Government forged an agreement with the health care company to ensure it remains listed.

Read The Australian article